Potent and competitive pituitary adenylate cyclase-activating polypeptide receptor (PAC)1
= 2 nM). Inhibits PACAP(1-27)-induced stimulation of adenylate cyclase (Ki
= 1.5 nM). Antitumor activity in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The neuropeptide PACAP promotes a-secretase pathway for processing Alzheimer amyloid precursor protein.
Kojro et al.
FASEB J., 2006;20:512
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist.
Robberecht et al.
PACAP(6-38) inhibits growth of prostate cancer cells.
Leyton et al.
Cancer Lett., 1998;125:131
The citations listed below are publications that use Tocris products. Selected citations for PACAP 6-38 include:
Showing Results 1 - 1 of 1